M. Wernli

发表

Chemotherapy patients' perceptions of drug administration safety.

D. Schwappach, David L.B. Schwappach, Martin Wernli, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of the Sysmex R-1000. An automated reticulocyte analyzer.

A. Gratwohl, A. Tichelli, A. Driessen, 1990, American journal of clinical pathology.

perspectives towards engaging in their safety Am I (un)safe here? Chemotherapy patients'

D. Schwappach, M. Wernli, 2010 .

Capecitabine in hormone-resistant metastatic prostatic carcinoma – a phase II trial

C. Rochlitz, H. Schmid, M. Borner, 2004, British Journal of Cancer.

Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research.

K. Rufibach, R. Stupp, J. Bernhard, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Weekly treatment with a combination of bortezomib and bendamustine in relapsed or refractory indolent non-Hodgkin lymphoma

M. Bargetzi, P. Moosmann, M. Wernli, 2010, Leukemia & lymphoma.

Predictors of chemotherapy patients' intentions to engage in medical error prevention.

D. Schwappach, M. Wernli, 2010, The oncologist.

Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia. Swiss Group for Clinical Cancer Research (SAKK).

M. Fey, A. Tobler, A. Tichelli, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Prostate cancer screening: results of a prospective trial in Canton Aargau, Switzerland.

M. Kwiatkowski, F. Recker, A. Huber, 2004, Swiss medical weekly.

Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV.

Martin C. Müller, N. Schmitz, J. Hasford, 2015, Blood.

High-risk additional chromosomal abnormalities at low blast counts herald death by CML

N. Schmitz, M. Stauch, Y. Ko, 2020, Leukemia.

Short remission durations in therapy-related leukemia despite cytogenetic complete responses to high-dose cytarabine.

R. Larson, M. L. Le Beau, J. Vardiman, 1988, Blood.

Vinorelbine in androgen-independent metastatic prostatic carcinoma--a phase II study.

B. Thürlimann, H. Schmid, M. Borner, 2002, European journal of cancer.

An intra-operative seminal and prostate emission test as a control for nerve-sparing procedures in primary and secondary retroperitoneal lymphadenectomy.

F. Recker, M. Goepel, P. Stucki, 1996, British journal of urology.

[Immunoglobulin deficiency after repeated plasmapheresis].

A. Gratwohl, A. Tichelli, B. Speck, 1991, Schweizerische medizinische Wochenschrift.

The Fake Three-Sided Key. Patient-Fabricated Duplicate Keys in Psychiatry around 1900

M. Wernli, 2019 .

Mobilization of peripheral blood progenitor cells with vinorelbine and granulocyte colony-stimulating factor in multiple myeloma patients is reliable and cost effective

R. Herrmann, A. Gratwohl, A. Tichelli, 2003, Bone Marrow Transplantation.

Progenitor cell mobilisation Mobilization of peripheral blood progenitor cells with vinorelbine and granulocyte colony-stimulating factor in multiple myeloma patients is reliable and cost effective

R. Herrmann, A. Gratwohl, J. Passweg, 2003 .

Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapies

L. Guillou, M. Fey, S. Leyvraz, 2006, British Journal of Cancer.

DV‐ICE, intensive induction and early transplantation for adult patients with acute lymphoblastic leukemia: a phase II study

A. Gratwohl, J. Passweg, A. Tichelli, 2009, European journal of haematology.

Short remission durations in therapy-related leukemia despite cytogenetic complete responses to high-dose cytarabine.

R. Larson, M. L. Le Beau, J. Vardiman, 1988, Blood.

The impact of the irinotecan (IRI) schedule on quality of life in combination with capecitabine (CAP) in first-line treatment of metastatic colorectal cancer (MCC): A randomized phase II trial of the Swiss Group for Clinical Cancer Research.

R. Herrmann, J. Bernhard, M. Borner, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: Report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL

P. Itin, M. Bargetzi, L. Borradori, 2001, American journal of hematology.

[Autologous transplantation of hematopoietic precursor cells following CD34 selection].

R. Herrmann, A. Gratwohl, A. Tichelli, 1996, Schweizerische medizinische Wochenschrift.

Medication errors in chemotherapy: incidence, types and involvement of patients in prevention. A review of the literature.

D. Schwappach, M Wernli, D L B Schwappach, 2010, European journal of cancer care.

Comparison of fluconazole with oral polyenes in the prevention of fungal infections in neutropenic patients

A. Gratwohl, M. Uhr, J. Passweg, 1995, Supportive Care in Cancer.

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

T. Brümmendorf, K. Spiekermann, M. Pfreundschuh, 2017, Leukemia.

Autologous bone marrow transplantation for recurrent malignant lymphoma after liver transplantation.

P. Morel, G. Mentha, L. Bühler, 1999, Transplantation.

[Cerebral metastasis in choriocarcinoma a case report].

A. Mironov, M. Bargetzi, M. Wernli, 2003, Praxis.

Intensive induction/consolidation therapy without maintenance in adult acute lymphoblastic leukaemia: a pilot assessment

H. Senn, A. Gratwohl, A. Tobler, 1994, British journal of haematology.

Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II study.

M. Ghielmini, M. Fey, A. Tobler, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV

J. Hasford, T. Brümmendorf, K. Spiekermann, 2018, Haematologica.

Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV

Martin C. Müller, H. Einsele, J. Hasford, 2014, Annals of Hematology.

Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study

R. Stupp, R. Stahel, M. Tötsch, 2006, British Journal of Cancer.

A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity.

R. Herrmann, J. Bernhard, M. Borner, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Efficient mobilization of PBSC with vinorelbine/G-CSF in patients with malignant lymphoma

A. Huber, P. Fernandez, J. Burger, 2009, Bone Marrow Transplantation.

The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK).

M. Ghielmini, R. Stupp, D. Betticher, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

complete responses to high-dose cytarabine Short remission durations in therapy-related leukemia despite cytogenetic

M. L. Beau, R. Larson, J. Vardiman, 2011 .

Features and preliminary results of prostate cancer screening in Canton Aargau, Switzerland

M. Kwiatkowski, F. Recker, A. Huber, 2003, BJU international.

Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial.

R. Stupp, R. Stahel, M. Tötsch, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oncology nurses' perceptions about involving patients in the prevention of chemotherapy administration errors.

D. Schwappach, M. Wernli, M. Hochreutener, 2010, Oncology nursing forum.

In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL.

T. Piironen, K. Pettersson, M. Kwiatkowski, 1998, Urology.

Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer.

R. Stupp, R. Herrmann, A. Goldhirsch, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I I S tudy o f C apecitabine a nd O xaliplatin i n F irst- and S econd-Line T reatment o f A dvanced o r M etastatic Colorectal C ancer

R. Stupp, R. Herrmann, A. Goldhirsch, 2002 .

Barriers and facilitators to chemotherapy patients' engagement in medical error prevention.

D. Schwappach, M Wernli, D L B Schwappach, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Flow cytometric monitoring of parasitaemia during treatment of severe malaria by exchange transfusion

A. Gratwohl, A. Tichelli, B. Speck, 1991, European journal of haematology.

Am I (un)safe here? Chemotherapy patients' perspectives towards engaging in their safety

D. Schwappach, M. Wernli, 2010, Quality and Safety in Health Care.

Mediast inal Lymph Node Clearance Af ter

R. Stupp, R. Stahel, M. Tötsch, 2009 .

Vinorelbine (NVB)-carboplatin (CBDCA) vs non-platinum doublets in inoperable non-small cell lung cancer (NSCLC) patients (pts)-final results of the Glob 2 phase III with patient benefit analysis.

E. Tan, A. Szczesna, O. Bertetto, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized study of vinorelbine--gemcitabine versus vinorelbine--carboplatin in patients with advanced non-small cell lung cancer.

M. Krzakowski, U. Gatzemeier, E. Tan, 2005, Lung cancer.

Weekly Treatment with a Combination of Bendamustine and Bortezomib in Relapsed or Refractory Indolent Non-Hodgkin’s Lymphoma: A Single- Center Phase 1/2 Study.

M. Bargetzi, P. Moosmann, M. Wernli, 2008 .

The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma

K. Pettersson, M. Kwiatkowski, F. Recker, 1998, Cancer.

Dicentric translocation (9;12) presenting as refractory Philadelphia chromosome-positive acute B-cell lymphoblastic leukemia.

A. Tichelli, M. Bargetzi, D. Mühlematter, 1999, Cancer genetics and cytogenetics.

Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV.

Martin C. Müller, N. Schmitz, J. Hasford, 2015, Blood.

Chemotherapy patients' perceptions of drug administration safety.

D. Schwappach, M. Wernli, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: Report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL

P. Itin, L. Borradori, M. Wernli, 2001, American journal of hematology.